Walgreens Boots Alliance (NASDAQ:WBA) Rating Reiterated by Raymond James

Walgreens Boots Alliance (NASDAQ:WBA)‘s stock had its “market perform” rating reissued by Raymond James in a report issued on Tuesday, Benzinga reports.

Other research analysts also recently issued reports about the company. Leerink Partnrs restated a “market perform” rating on shares of Walgreens Boots Alliance in a research note on Monday, February 26th. SVB Leerink dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set a “market perform” rating for the company in a research note on Monday, March 18th. Bank of America dropped their price target on Walgreens Boots Alliance from $23.00 to $22.00 and set an “underperform” rating for the company in a research note on Tuesday. TheStreet upgraded Walgreens Boots Alliance from a “d+” rating to a “c-” rating in a research note on Monday, January 8th. Finally, Barclays assumed coverage on Walgreens Boots Alliance in a research report on Wednesday, January 3rd. They set an “underweight” rating and a $21.00 target price for the company. Four analysts have rated the stock with a sell rating, ten have given a hold rating and one has assigned a buy rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus target price of $25.00.

Walgreens Boots Alliance Trading Up 2.5 %

Shares of NASDAQ:WBA opened at $21.02 on Tuesday. The stock has a 50 day moving average of $21.75 and a 200 day moving average of $22.29. The company has a market cap of $18.13 billion, a PE ratio of 31.85, a price-to-earnings-growth ratio of 1.27 and a beta of 0.73. The company has a current ratio of 0.66, a quick ratio of 0.30 and a debt-to-equity ratio of 0.27. Walgreens Boots Alliance has a 12-month low of $19.68 and a 12-month high of $36.58.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Thursday, January 4th. The pharmacy operator reported $0.66 earnings per share for the quarter, topping the consensus estimate of $0.62 by $0.04. Walgreens Boots Alliance had a return on equity of 10.48% and a net margin of 0.40%. The business had revenue of $36.70 billion during the quarter, compared to the consensus estimate of $34.95 billion. During the same period in the prior year, the company posted $1.16 EPS. The firm’s revenue for the quarter was up 9.9% compared to the same quarter last year. As a group, equities research analysts expect that Walgreens Boots Alliance will post 3.24 EPS for the current year.

Insider Activity at Walgreens Boots Alliance

In related news, Director Valerie B. Jarrett purchased 4,456 shares of the firm’s stock in a transaction that occurred on Monday, January 29th. The shares were bought at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the acquisition, the director now owns 4,456 shares of the company’s stock, valued at approximately $99,992.64. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other Walgreens Boots Alliance news, Director Valerie B. Jarrett bought 4,456 shares of Walgreens Boots Alliance stock in a transaction on Monday, January 29th. The shares were acquired at an average price of $22.44 per share, for a total transaction of $99,992.64. Following the completion of the purchase, the director now directly owns 4,456 shares in the company, valued at approximately $99,992.64. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CEO Timothy C. Wentworth bought 10,000 shares of Walgreens Boots Alliance stock in a transaction on Friday, January 5th. The stock was acquired at an average price of $24.22 per share, for a total transaction of $242,200.00. Following the purchase, the chief executive officer now owns 585,122 shares of the company’s stock, valued at $14,171,654.84. The disclosure for this purchase can be found here. 17.40% of the stock is currently owned by insiders.

Institutional Trading of Walgreens Boots Alliance

Hedge funds and other institutional investors have recently bought and sold shares of the business. EverSource Wealth Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 308.4% in the third quarter. EverSource Wealth Advisors LLC now owns 1,119 shares of the pharmacy operator’s stock valued at $25,000 after acquiring an additional 845 shares in the last quarter. Highlander Capital Management LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Pineridge Advisors LLC bought a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at about $26,000. Venturi Wealth Management LLC raised its holdings in shares of Walgreens Boots Alliance by 1,241.8% in the fourth quarter. Venturi Wealth Management LLC now owns 1,060 shares of the pharmacy operator’s stock valued at $28,000 after acquiring an additional 981 shares in the last quarter. Finally, FinTrust Capital Advisors LLC raised its holdings in shares of Walgreens Boots Alliance by 2,314.5% in the third quarter. FinTrust Capital Advisors LLC now owns 1,328 shares of the pharmacy operator’s stock valued at $30,000 after acquiring an additional 1,273 shares in the last quarter. Hedge funds and other institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.